RCMNY
IART icon

Rubric Capital Management (New York)’s Integra LifeSciences IART Stock Holding History

Rubric Capital Management (New York)’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139M Hold
7,753,934
– – 1.28% 23
2026
Q1 		$73M Hold
7,753,934
– – 0.77% 29
2025
Q4 		$96.3M Buy
7,753,934
+100,000
+1% +$1.33M 1.15% 22
2025
Q3 		$110M Buy
7,653,934
+300,000
+4% +$4.11M 1.24% 19
2025
Q2 		$90.2M Buy
7,353,934
+2,710,262
+58% +$39.4M 1.36% 23
2025
Q1 		$102M Buy
4,643,672
+2,025,331
+77% +$47.6M 1.83% 14
2024
Q4 		$59.4M Buy
2,618,341
+2,325,258
+793% +$50.8M 0.76% 27
2024
Q3 		$5.33M Buy
+293,083
New +$6.79M 0.09% 57

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Rubric Capital Management (New York)'s IART Position: Q2 2026 in Review

Rubric Capital Management (New York) held its Integra LifeSciences (IART) position steady in Q2 2026 at 7,753,934 shares worth $139M. The position accounts for 1.28% of the portfolio, ranked #23.

Rubric Capital Management (New York) first reported a position in IART in Q3 2024 and has held it in 8 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Rubric Capital Management (New York) held 7,753,934 shares of Integra LifeSciences worth $139M as of Q2 2026.
  • Rubric Capital Management (New York) left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up 1.28% of Rubric Capital Management (New York)'s portfolio in Q2 2026, its #23 holding.
  • Rubric Capital Management (New York) first reported a position in Integra LifeSciences in Q3 2024 and has held it in 8 quarters since.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.